Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients
Status:
Unknown status
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effects of Cholecalciferol (Vitamin D3)
substitution on the posttransplant outcome (glomerular filtration rate as well as serum
creatinine levels, number of acute rejection episodes, number of infections and C-reactive
protein levels within the first year after transplantation) in vitamin D deficient kidney
transplant recipients.
Phase:
Phase 3
Details
Lead Sponsor:
Medical University of Vienna
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins